This PrPmtA transgenic strain expresses mutant human A53T alpha-synuclein (SNCA). Homozygotes may be a useful model for early stages of Parkinson's Disease, in particular to study the mechanisms of striatal synaptic plasticity, and may become a useful tool to study mechanisms of LevoDopa-induced dyskinesia.
Georg Auburger, University Medical School
These transgenic mice express the mutant A53T human alpha-synuclein (SNCA) under the direction of the mouse prion protein promoter in nigrostriatal and corticostriatal projection neurons, but not local striatal neurons. The A53T mutation is associated with
early onset familial Parkinson's disease. Transgene expression levels are 1.5-2 fold greater than endogenous mouse gene expression levels. Homozygotes older than 6 months of age display progressively spontaneous vertical movement (rearing). At 7 months of age, dense alpha-synuclein immunoreactive resembling Lewy neurites is detected in the olfactory bulb. Ultrastructural examination of neurons reveals diffuse accumulation of human alpha-synuclein. A53T SCNA protein is detected in neuronal axons, dendrites, cell bodies, and nuclei throughout the CNS by immunohistochemical analysis (including: olfactory bulb, cerebral cortex, hippocampus, midbrain, pons, medulla oblongata). Mice 18 months of age and older display insoluble alpha-synuclein in nigrostriatal tissue together with an increase of 14-3-3 isoforms in striatum, elevated striatal dopamine levels, altered dopamine release, decreased transcript levels of the extraneural dopamine degradation enzyme COMT, upregulated striatal dopamine receptors, decreased postsynaptic dopamine response in Homer1 (homer homolog 1 (Drosophila)), Cb1 (cannabinoid receptor 1 (brain)) and Pde7b (phosphodiesterase 7B) transcript levels as well as impaired corticostriatal long term depression. Survival of homozygotes at 24 months of age is lower than survival of wildtype controls. Mice homozygous for the transgenic insert are viable, fertile, and normal in size.
A transgenic construct containing the entire translated portion of the mutant A53T human alpha-synuclein (SNCA) from position 22 to 515, driven by an ~3.5 kb fragment of the mouse prion protein promoter (Prnp), and polyadenylation signal sequence, was injected into fertilized FVB/N mouse eggs. Founder line A was subsequently established. The transgenic mice were then crossed to a targeted mutation strain on the 129 background. Upon arrival at The Jackson Laboratory, the double mutant mice were crossed to FVB/NJ (Stock No. 001800) at least once to establish the colony. The transgene was then separated from the double mutant by selective breeding to establish this strain.
|Expressed Gene||SNCA, synuclein alpha, human|
|Site of Expression|
|Allele Name||transgene insertion A, Georg Auburger|
|Allele Type||Transgenic (Inserted expressed sequence, Humanized sequence)|
|Allele Synonym(s)||Tg(Prnp-SNCA*A53T)AAub; transgene insertion A, Georg Auburger|
|Gene Symbol and Name||Tg(Prnp-SNCA*A53T)AAub, transgene insertion A, Georg Auburger|
|Gene Synonym(s)||PrPmtA; A53T; Tg(Prnp-SNCA*A53T)BAub; PrPmtB; Tg(Prnp-SNCA*A53T)BAub; transgene insertion B, Georg Auburger|
|Promoter||Prnp, prion protein, mouse, laboratory|
|Expressed Gene||SNCA, synuclein alpha, human|
|Strain of Origin||FVB/N|
|Molecular Note||A construct containing the entire translated portion of human alpha-synuclein, SNCA from position 22 to 515, driven by an ~3.5 kb fragment of the mouse prion protein promoter, Prnp, was generated. The SNCA cDNA was followed by polyadenylation sequences derived from the 3' untranslated region of the boving growth hormone gene. This construct was microinjected into pronuclei of fertilized FVB/N ova. Transgenic protein expression was detected in the neuropil, with, more rarely, additional protein within neuronal cell bodies and neurites in the brain and motoneurons in the spinal cord. Two lines, A and B, were generated, have both been extensively studied, showing extremely similar phenotypes (J:86222, J:124976).|
|Mutations Made By|| |
Robert Nussbaum, University of California San Francisco
When maintaining a live colony, these mice can be bred as homozygotes. However, survival of homozygotes at 24 months of age is lower than survival of wildtype controls.
When using the FVB;129-Tg(Prnp-SNCA*A53T)AAub/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #017744 in your Materials and Methods section.
|Hemizygous or Non Carrier for Tg(Prnp-SNCA*A53T)AAub|
We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.